| Jul 2 |
Will Black Diamond Therapeutics (NASDAQ:BDTX) Spend Its Cash Wisely?
|
| Jun 30 |
Is Black Diamond Therapeutics, Inc. (BDTX) a Good Biotech Penny Stock to Buy Right Now?
|
| Jun 27 |
Black Diamond: High-Risk, High-Reward, Low-Profile EGFR Inhibitor Worth A Deep Dive
|
| Jun 1 |
Black Diamond Therapeutics Presents Promising BDTX-1535 Clinical Data in Patients with Recurrent Glioblastoma at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
|
| May 29 |
Black Diamond Therapeutics to Participate in Jefferies Global Healthcare Conference
|
| May 22 |
Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) is favoured by institutional owners who hold 60% of the company
|
